New oral GLP-1 reduces more glucose and weight than semaglutide in phase 3 study; Orforgliprona increases weight loss by 73%
The experimental drug orforgliprona demonstrated greater glucose control and weight loss compared to oral semaglutide in a phase 3 study for type 2 diabetes treatment.
Polylaminin: Tetraplegic athlete from Paraná applies compound that 'trended' with positive motor recovery results
A tetraplegic athlete in Brazil has seen positive results from an experimental treatment using polylaminin, a compound derived from a protein produced in the human body.
This is Fantastic: the advances in experimental treatments with polylaminin
The article discusses promising advancements in experimental treatments involving polylaminin, a placenta-derived protein that may restore movement in patients with severe spinal cord injuries.
Polylaminin: student from Balsas is the second patient in MA to receive the substance
Hector Lucena, a 26-year-old agriculture student from Balsas, became the second person in Maranhão to receive polylaminin during an experimental procedure on November 21.
Daily recap #1868: Argentina's Chamber approves labor reform, which returns to the Senate; US Supreme Court decides on legality of Trump's tariff; The steps of experimental treatment with polylaminin
Argentina's Chamber of Deputies has approved a labor reform which now goes back to the Senate, while the US Supreme Court is set to rule on Trump's tariff legality, and a patient has regained ability to walk thanks to a new treatment with polylaminin.
First maranhense to receive polylaminin, shot PM shows improvement
Military police officer Romildo Leobino is showing signs of improvement after undergoing an experimental treatment with polylaminin following his injury during an operation.
Polylaminin: student shot inside school in PI cannot participate in innovative treatment
João Lucas Campelo, a 17-year-old student who became quadriplegic after being shot, is unable to undergo an experimental polylaminin treatment due to his health condition and other constraints.
Cellular Implant Against Parkinson's Tested on Humans
Researchers at USC's Keck Medicine Medical Center are testing an experimental stem cell implant on Parkinson's patients to restore dopamine production in the brain.
Youngest patient in the country to receive polylaminin reports movement in his hands: 'I couldn't move before'
Luiz Otávio Santos Nunez, the youngest patient in Brazil to receive polylaminin, reports regaining some movement in his fingers following the experimental treatment after a serious injury.
Podcast: the Brazilian experimental drug that may be hope for spinal cord injuries
The podcast discusses polylaminin, an experimental drug showing promise in restoring movement for patients with spinal cord injuries, highlighted by the case of a Brazilian influencer who regained arm movement after treatment.
Crans-Montana Fire: Burn Victims Will Be Treated Thanks to This Marine Worm
French researchers have developed a gel containing a molecule from a marine worm that promotes healing, which will soon be used to treat burn victims from the tragic fire in Crans-Montana.
Could there be a link between glucose levels in the brain and Alzheimer’s disease?
A Chinese study found that mice with late-stage Alzheimer's symptoms showed memory improvement and reduced brain plaque after receiving an experimental treatment targeting glucose levels in the brain.
The pastry chef who patented a molecule against cancer that has sold for 7 billion euros
Eduard Batlle, raised in his parents' bakery, is one of the inventors of petosemtamab, a groundbreaking experimental treatment for tumors that has achieved significant financial success.